Who owns TENAX THERAPEUTICS INC?
- Ticker: TENX
- CUSIP Number: 88032l605
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tenax Therapeutics stock
Who bought or sold TENAX THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 968k | $12M | 0% | Dec 2025 |
|
| Siren | 427k | $5.2M | 21% | Dec 2025 |
|
| Point72 Asset Management | 423k | $5.2M | 100% | Dec 2025 |
|
| Rtw Investments | 378k | $4.6M | 0% | Dec 2025 |
|
| Boothbay Fund Management | 352k | $4.3M | 0% | Dec 2025 |
|
| BVF | 340k | $2.6M | 0% | Sep 2025 |
|
| Millennium Management | 314k | $2.4M | 34% | Sep 2025 |
|
| Marshall Wace | 298k | $3.6M | 68% | Dec 2025 |
|
| Vanguard Group | 256k | $3.1M | 58% | Dec 2025 |
|
| Diadema Partners | 243k | $3.0M | 100% | Dec 2025 |
|
| Vivo Capital | 208k | $2.5M | 0% | Dec 2025 |
|
| Sphera Funds Management | 190k | $2.3M | 100% | Dec 2025 |
|
| Integral Health Asset Management | 167k | $2.0M | 0% | Dec 2025 |
|
| Henderson Group | 167k | $1.3M | 100% | Sep 2025 |
|
| Woodline Partners | 144k | $1.7M | 63% | Dec 2025 |
|
| Renaissance Technologies | 126k | $1.5M | 122% | Dec 2025 |
|
| Velan Capital Investment Management | 83k | $1.0M | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 83k | $634k | 0% | Sep 2025 |
|
| Persistent Asset Partners | 65k | $796k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 64k | $776k | 19% | Dec 2025 |
|
| Geode Capital Management | 56k | $679k | 62% | Dec 2025 |
|
| Vestal Point Capital | 53k | $651k | 0% | Dec 2025 |
|
| Citadel Advisors | 43k | $329k | 318% | Sep 2025 |
|
| Artia Global Partners | 42k | $513k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 22k | $273k | 100% | Dec 2025 |
|
| Quadrature Capital | 21k | $252k | 100% | Dec 2025 |
|
| BlackRock | 17k | $204k | 5453% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 15k | $187k | 100% | Dec 2025 |
|
| CI Private Wealth | 12k | $151k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 12k | $145k | 100% | Dec 2025 |
|
| Letko, Brosseau & Associates | 11k | $130k | 100% | Dec 2025 |
|
| UBS Group | 676.00 | $8.1k | 468% | Dec 2025 |
|
| Tower Research Capital | 199.00 | $2.4k | -60% | Dec 2025 |
|
| Union Bancaire Privee, UBP SA | 1.00 | $9.000000 | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.00 | $12.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 1.00 | $12.000000 | -50% | Dec 2025 |
|
| Hanson McClain Advisors | 1.00 | $13.000000 | 0% | Dec 2025 |
|
| UMA Financial Services | 1.00 | $13.000000 | 0% | Dec 2025 |
|
Who sold out of Tenax Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| VR Adviser | Sep 2025 | 438k | $3.3M |
| Virtu Financial | Sep 2025 | 12k | $92k |
| DRW Holdings | Sep 2025 | 11k | $80k |
| SBI Securities | Sep 2025 | 2.00 | $15.000000 |
| Sontag Advisory | Sep 2025 | 1.00 | $8.000000 |